QLINE logo

Q-line Biotech Limited

QLINE·NSE·
635.00 -2.60 (-0.41%)
Market Cap1244.79 Cr
PE Ratio18.55
Volume56,000
Day High - Low655.00 - 635.00
52W High-Low659.75 - 431.00
DocStoX Score
7.0/10
Strong
Fair Value
Sign in to see
ROE
25.90%
Strong
P/E
18.55x
Fair
Debt / Equity
0.75
Moderate
Industry
Healthcare
Medical Equipment & Supplies
Overall View
Strong

Price performance

Day635.00
655.00
52W431.00
659.75
DocStoX take

Supported by growth (7.8) and quality (7.6), but weakest on risk (4.9).

DocStoX score

Low confidence
7.0
/10
Strong
Quality
Excellent
ROE 25.9%
Valuation
Fair
P/E 18.6×
Growth
Strong
Revenue +23.2% 3Y CAGR
Risk
Elevated
D/E 0.75
Momentum
Strong
89% of 52-week range

At a glance

Market Cap
₹1,245 Cr
52W High / Low
₹660 / ₹431
Dividend Yield
0.00%
Promoter Holding
67.51%
EPS (TTM)
₹34.24
Book Value
₹209.24

Key highlights

  • Profitable in all of the last 4 years
  • Strong returns on equity (26%)
  • Revenue compounding 23% a year
4 Positives0 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Medical Equipment & Supplies

Q-LINE BIOTECH LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.